CORT
Corcept Therapeutics Incorporated
122.00$
+5.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 72.6% | 73.8% | 76.7% | 78.5% | 59.5% | 56.1% | 51.8% | 55.3% | 65.7% | 58.0% | 52.3% | 49.5% | |
| 18.8% | 21.8% | 22.8% | 18.0% | 17.5% | 15.2% | 10.6% | 12.8% | 15.2% | 14.4% | 13.3% | 12.5% | |
| 59.8% | 59.2% | 62.6% | 66.2% | 48.5% | 45.6% | 38.1% | 42.7% | 51.2% | 44.5% | 41.5% | 34.7% | |
| 8.4% | 9.1% | 9.7% | 7.9% | 8.0% | 6.9% | 10.0% | 8.6% | 8.9% | 7.1% | 4.8% | 8.7% | |
| 1.3% | 1.2% | 1.1% | 1.2% | 1.0% | 1.5% | 1.7% | 1.5% | 1.5% | 1.5% | 1.6% | 1.5% | |
| 0.1% | – | – | – | – | – | – | – | – | – | – | – | |
| 22.3% | 18.5% | 16.5% | 16.6% | 18.5% | 19.1% | 19.3% | 20.7% | 23.3% | 22.6% | 21.7% | 20.6% | |
| 20.5% | 16.8% | 14.8% | 14.1% | 16.1% | 16.7% | 16.9% | 18.0% | 20.9% | 19.9% | 18.3% | 17.3% | |
| 0.0% | 0.0% | 0.0% | 0.0% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.1% | 0.2% | 0.2% | |
| 2.8% | 2.8% | 1.9% | 2.7% | 2.4% | 1.8% | 3.3% | 2.9% | 4.2% | 4.8% | 4.1% | 1.7% | |
| 77.7% | 81.5% | 83.5% | 83.4% | 81.5% | 80.9% | 80.7% | 79.3% | 76.7% | 77.4% | 78.3% | 79.4% | |
| 62.5% | 64.8% | 65.6% | 65.2% | 65.4% | 64.7% | 66.7% | 74.8% | 75.2% | 76.9% | 75.1% | 73.7% | |
| 18.7% | 17.8% | 16.8% | 15.6% | 14.5% | 14.1% | 14.2% | 15.0% | 14.5% | 14.3% | 12.8% | 13.3% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.